Liothyronine
Indication
Liothyronine for the treatment of acute conditions where thyroid replacement is needed rapidly, for a limited period and/or where a drug with shorter half-life is required.
Red
Brand:
Tertroxin®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Prescribing by secondary or tertiary care specialists for the treatment of acute conditions where thyroid replacement is needed rapidly and where a drug with shorter half-life is required. This includes thyroid cancer patients awaiting radioiodine scan or therapy.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: